We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Orion Continues Patent Battle Against Generic Stalevo

Law360 (December 10, 2008, 12:00 AM EST) -- Pharmaceutical company Orion Corp. shot off a lawsuit Monday in an effort to stop Wockhardt Ltd. from marketing a generic version of Stalevo, a treatment for Parkinson's disease, the latest in a number of suits Orion has filed to protect patents related to Stalevo and another Parkinson's drug, Comtan.

The suit, filed in the U.S. District Court for the District of Delaware, accuses Wockhardt and a U.S. subsidiary of infringing three patents that cover the drug.

Orion, a Finnish company, had previously sued India-based Wockhardt for...
To view the full article, register now.